Board Performance · 2025
In this section14 topics
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives7 items
- Selection of Independent Directors3 items
- Director Development1 item
- Evaluation of Board & Subcommittee Performance4 items
- Subcommittees1 item
- Meeting Attendance & Remuneration4 items
- Supervision of Subsidiaries & Associated Companies5 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The Company has established a policy for preventing conflicts of interest to serve as a guideline for considering transactions that may involve conflicts of interest for directors and executives. It also monitors and ensures that directors and executives disclose their own interests and those of related persons concerning the management of the Company or its subsidiaries, in accordance with the criteria for related party transactions set by the SEC and the Stock Exchange. The Company Secretary is responsible for coordinating the preparation of such disclosure documents, and the accounting and finance departments are responsible for surveying transactions with interests before presenting the information to the Audit Committee and the Board of Directors annually or when changes occur.
In 2025, the Company reviewed the adequacy and appropriateness of its conflict of interest prevention policy and communicated it to directors, executives, and employees to ensure their understanding and ability to act correctly in accordance with the established policy.
|
Policy Communication |
|
of trainees (percentage) |
||||
|
Board of Directors |
Executives |
Employees |
Board of Directors |
Executives |
Employees |
|
|
Policies and Guidelines on Prevention of Conflicts of Interest |
100 |
100 |
100 |
100 |
100 |
86.46 |
Operations regarding connected transactions or related party transactions
For connected transactions or related party transactions between the Company and its subsidiaries and individuals who may have conflicts of interest, have an interest, or may have future conflicts of interest with the Company, such as directors, executives, major shareholders, controlling persons, and their related parties, the Company has complied with the Securities and Exchange Act, regulations, announcements, and orders of the Capital Market Supervisory Board, the Securities and Exchange Commission (“SEC”), and the Stock Exchange of Thailand (“SET”). This includes compliance with the requirements for disclosing connected transactions or related party transactions in the notes to the financial statements audited by the Company's auditor and in the annual registration statement (56-1 One Report) / annual report. Interested parties are not permitted to participate in the consideration or approval of such transactions, nor do they have the right to vote to approve such transactions, as stipulated in the policy on connected transactions or related party transactions.
In the past year, the Company arranged for Audit Committee meetings to consider and provide opinions on the necessity and reasonableness of transactions, under a framework of good ethics, before presenting their opinions to the Board of Directors meeting. The Board of Directors ensures that such transactions comply with the criteria of the Capital Market Supervisory Board and the Securities and Exchange Commission, and also considers the disclosure of information regarding connected transactions or related party transactions to the public to be accurate and complete in accordance with the criteria. Entering into such transactions will not involve the transfer or diversion of benefits of BLC or BLC's shareholders, but rather transactions that prioritize the best interests of BLC and all shareholders.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The Company prioritizes the protection of rights and building confidence for investors and shareholders by establishing a policy on the use of inside information and securities trading by directors, executives, and employees, in compliance with relevant laws and regulations. Directors and executives are obligated to report their holdings and changes in their securities holdings, as well as those of related persons, to regulatory authorities within the specified period and submit copies to the Company for acknowledgment. Insiders are prohibited from using or disclosing non-public information that may affect securities prices, as well as from disseminating false or misleading information or using inaccurate information for analysis or forecasting that may impact investment decisions. Furthermore, it is mandated to maintain the confidentiality of the Company and its partners, use inside information solely for the Company's benefit, and prevent information leakage through document control measures, communication, and restricted access to information. Directors, executives, and employees are prohibited from trading securities or disclosing information during the 1-month period before financial statements or other price-sensitive information is publicly disclosed, and must not trade securities until 24 hours after such information has been made public. Any violation of this policy constitutes an offense under the law and the Company's disciplinary rules, with penalties determined by the severity and intent of the act.
In 2025, the Company will review the adequacy and current suitability of its policy on preventing the use of inside information and securities trading by directors, executives, and employees, and communicate it to directors, executives, and employees to ensure their understanding and proper compliance with the said policy.
|
Policy communication |
|
of training participants (percentage) |
||||
|
Board of Directors |
Executives |
Employees |
Board of Directors |
Executives |
Employees |
|
|
Policies and guidelines regarding Prevention of using inside information for personal gain |
100 |
100 |
100 |
100 |
100 |
72.45 |
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company prioritizes the prevention and suppression of all forms of corruption to protect the rights and enhance the confidence of investors, shareholders, and stakeholders. It has established a policy requiring directors, executives, employees, subsidiaries, agents, and all relevant parties to perform their duties with integrity, transparency, and an anti-corruption mindset. The policy is publicly disclosed on the Company's website in compliance with relevant laws and regulations. Anti-corruption risk assessments are mandated for operational processes. Compliance with the policy is part of the internal audit plan, and the adequacy of measures is reviewed by the Audit Committee, with continuous reporting to the Board of Directors. Furthermore, guidelines and requirements are regularly reviewed to align with changes in business, regulations, and legal requirements.
In 2025, the Company reviewed the adequacy and current suitability of its anti-corruption policy and communicated it to directors, executives, and employees to ensure their understanding, proper conduct, and compliance with the policy. Additionally, an internal audit of the procurement process for corruption was conducted during the fourth quarter of 2025.
Policy Communication | | of training participants (percentage) | ||||
Board of Directors | Executives | Employees | Board of Directors | Executives | Employees | |
Policies and practices regarding Anti-corruption | 100 | 100 | 100 | 100 | 100 | 91.84 |
Form of Anti-Corruption Operations
| Operation |
|---|
| Review of appropriateness in anti-corruption |
| Communication and training for employees on anti-corruption policy and guidelines |
| Review of the completeness and adequacy of the process by the Audit Committee or auditor |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
The company provides opportunities for both internal and external stakeholders to report tips or complaints regarding misconduct through various channels as deemed appropriate, as follows:
1 Cases related to corruption
By email : To the Chairman of the Audit Committee at E-mail : fraud-complaint@bangkoklab.co.th
By mail : To the Chairman of the Audit Committee, Address 48/1 Moo 5 Nong Cha Sao Road, Nam Phu Subdistrict, Mueang District, Ratchaburi Province 70000 By marking the envelope "Confidential"
By establishing a consideration process, as well as providing measures for protection and compensation for damages to whistleblowers or complainants.
In accordance with the company's whistleblowing and complaint policy
2 Cases not related to corruption
By email: To Human Resources Manager at E-mail : complaint@bangkoklab.co.th
By mail: To Human Resources Manager, Address 48/1 Moo 5 Nong Cha Sao Road, Nam Phu Subdistrict, Mueang District, Ratchaburi Province 70000
Via website: https://bangkoklab.co.th
By phone: Human Resources Manager 0-32-719900 to 225
The Human Resources Manager shall gather preliminary information and report it to the executives for coordination and corrective action, then inform the Chairman of the Audit Committee for acknowledgment.
In 2025, the company reviewed the adequacy and appropriateness of its whistleblowing and complaint policy and communicated it to directors, executives, and employees to ensure understanding and proper conduct.
Policy Communication | | of training participants (percentage) | ||||
Board of Directors | Executives | Employees | Board of Directors | Executives | Employees | |
Policies and Guidelines regarding Whistleblowing or Complaints | 100 | 100 | 100 | 100 | 100 | 94.17 |
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Selection — Introduction
The Company recruits individuals for appointment as directors through the Nomination and Remuneration Committee. The Nomination and Remuneration Committee comprises 2 independent directors out of a total of 3 members. The Chairman of the Nomination and Remuneration Committee is an independent director. This committee is responsible for selecting and screening qualified individuals in accordance with the Company's Articles of Association, before submitting recommendations to the Board of Directors for approval and subsequently presenting the list to the shareholders' meeting for further consideration and election, in accordance with the Company's criteria and procedures for director nomination.
In 2025, the Company provided an opportunity for shareholders to nominate qualified individuals for consideration for election as directors to replace those whose terms were expiring, in advance, from October 1, 2024, to December 30, 2024. The Company published the established criteria and guidelines on its website and through the channels of the Stock Exchange of Thailand. Upon the expiration of the aforementioned period, no shareholder nominated any individual for consideration for appointment as a director.
Directors & Chief Executives — Introduction
Recruitment of Directors
The Company recognizes and emphasizes the importance of recruiting and appointing directors to ensure that selected individuals can perform their duties effectively and in line with the Company's business strategy. Therefore, principles and methods for the recruitment and appointment of directors have been established to ensure that the process is systematic, transparent, compliant with relevant regulations, rules, and laws, and consistent with good corporate governance principles. The Nomination and Remuneration Committee is tasked with considering and screening individuals to be nominated for directorship to the Board of Directors before submitting them to the Shareholders' Meeting for election. The recruitment criteria are as follows:
Shareholders of the Company (who may be a single shareholder or multiple shareholders combined) holding not less than 5% of the total voting rights of the Company (or representing not less than 30 million shares, calculated from the Company's current paid-up registered capital) as of the date of advance agenda submission, are given the opportunity to nominate suitable individuals with knowledge and ability for consideration as directors of the Company. The Company will announce the timeframe, methods, and conditions for nominating directors through the Stock Exchange of Thailand in advance of the Annual General Meeting of Shareholders.
The Nomination and Remuneration Committee may consider suitable candidates from the Director’s Pool and databases of reputable organizations, such as the list of professional directors in the directory of the Thai Institute of Directors Association (IOD Chartered Director), and/or by compiling a list of individuals with knowledge, abilities, and expertise in various fields that would benefit the operations of the Group.
Nominated candidates for the Company's directorship must possess full qualifications and comply with relevant laws, regulations, rules, and requirements. Furthermore, they must not exhibit characteristics indicating a lack of suitability to be entrusted with managing a public company, as stipulated by the Securities and Exchange Commission and/or the Capital Market Supervisory Board and the Stock Exchange of Thailand. In the case of nominating independent directors, their independence qualifications will be further considered in accordance with the announcements of the Capital Market Supervisory Board.
The Nomination and Remuneration Committee is responsible for nominating directors to replace those whose terms have expired or in other cases. This involves verifying and selecting qualified individuals in accordance with Item 3 from the lists nominated by shareholders and/or the Nomination and Remuneration Committee as per Items 1 and 2. The Committee also considers diversity in the board's composition, transparency, integrity, knowledge, abilities, professional skills, expertise, and specific experience beneficial and consistent with the Company's business strategy, as outlined in the Board Skill Matrix, before submitting the nominations to the Board of Directors' Meeting and/or the Shareholders' Meeting for approval.
At every Annual General Meeting of Shareholders, one-third (1/3) of the Company's directors shall retire by rotation. If the number of directors due to retire by rotation cannot be divided exactly by three, the number closest to one-third shall retire, and the director who has held office for the longest period shall be the one to retire. Retiring directors may be re-elected to their positions. Their performance over the past year, dedication of time to duties, and participation in various activities, both as a Company director and as a member of sub-committees, will be taken into additional consideration.
If a director's position becomes vacant for reasons other than retirement by rotation, the Board of Directors, upon the recommendation of the Nomination and Remuneration Committee, shall appoint a qualified individual in accordance with Item 3 as a replacement director at the next Board meeting, unless the remaining term of that director is less than 2 months, in which case the Board of Directors may choose not to appoint a replacement. The replacement director shall hold office only for the unexpired portion of the term of the director they are replacing.
Recruitment of the Chief Executive Officer
The Company recognizes the importance of efficient organizational operations and ensuring continuous personnel support to prevent business disruptions. Therefore, a Succession Plan has been developed as a guideline for the recruitment and preparation of senior executives and the development of individuals with the potential to succeed in key positions for the sustainable management and operation of the organization. This plan aims to mitigate human resource risks for the Company, which requires focus from executives at all levels to build long-term strength for the Company. The Chief Executive Officer is a position that must be recruited and developed according to the processes of the aforementioned succession plan, as are executives at the director and department manager levels. The Nomination and Remuneration Committee is tasked with considering and screening individuals to be nominated for the position of Chief Executive Officer, to ensure the selection of individuals with the necessary knowledge, skills, experience, and attributes to drive the organization towards its goals. This includes overseeing the establishment of adequate compensation structures and performance evaluations at all levels, comparable to similar industrial businesses, and monitoring the management and development of personnel to possess appropriate knowledge, skills, experience, and motivation before submitting for the Board of Directors' approval.
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
1
Rights of Minority Shareholders on Director Appointment
The Company provided an opportunity for minority shareholders to nominate qualified individuals for election as directors in place of those retiring by rotation, in advance, from October 1, 2024, to December 30, 2024. The Company published the prescribed criteria and guidelines on its website and through the channels of the Stock Exchange of Thailand. Upon the expiration of the said period, no shareholder nominated any individual for consideration for appointment as a director. Nominated individuals must undergo consideration by the Nomination and Remuneration Committee in accordance with the criteria and procedures for director nomination, which will take into account the diversity of directors, professional skills, abilities, experience, and specialized expertise, as well as alignment with the Company's business strategies, and ensure that they do not possess any prohibited characteristics as stipulated by law.
The appointment of directors at the Shareholders' Meeting will allow for individual voting for each director. Each share shall be counted as one vote, and votes cannot be split. The candidates receiving the highest number of votes in descending order shall be elected as directors, up to the number of directors to be elected at that meeting. In the event of a tie, the Chairman of the meeting shall cast an additional vote as a deciding vote.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Selection Criteria — Introduction
Independent directors must not serve as executives, be independent from management and controlling shareholders, have no business relationship with the company that would restrict their ability to express independent opinions, and must possess qualifications as prescribed by the Capital Market Supervisory Board's notification.
Criteria for Selecting Independent Directors
Holding no more than 1 percent of the total voting shares of the company, its subsidiaries, associates, major shareholders, or controlling persons of the company. This includes the shareholding of related persons of the independent director.
those specific cases as well.
Not having or having had involvement in management, and not being or having been an employee, staff member, salaried advisor, or controlling person of the company, its subsidiaries, associates, major shareholders, or controlling persons of the company, unless such characteristics have ceased for at least two years prior to the appointment. However, the aforementioned prohibited characteristics do not include cases where the independent director was previously a government official or an advisor to a government agency which is a major shareholder or controlling person of the company.
Having no blood relationship or legal registration as a father, mother, spouse, sibling, or child, including the spouse of a child, of other directors, executives, major shareholders, controlling persons of the company, or individuals proposed to be directors, executives, or controlling persons of the company or its subsidiaries.
Not having or having had a business relationship with the company, its subsidiaries, associates, major shareholders, or controlling persons of the company in a manner that may impede their independent judgment, and not being or having been a significant shareholder or controlling person of those who have a business relationship with the company, its subsidiaries, associates, major shareholders, or controlling persons of the company, unless such characteristics have ceased for at least two years prior to the appointment.
- The business relationship mentioned in the first paragraph includes ordinary commercial transactions for business operations, property leasing or rental, transactions related to assets or services, or the provision or receipt of financial assistance through borrowing or lending, guarantees, or the pledging of assets as collateral for debts, as well as other similar circumstances, which result in the company or the counterparty having a debt obligation to the other party of at least 3 percent of the company's net tangible assets or 20 million baht or more, whichever amount is lower. The calculation of such debt obligations shall follow the method for calculating the value of connected transactions as per the Capital Market Supervisory Board's notification regarding rules for connected transactions by analogy. However, when considering such debt obligations, debt obligations incurred within one year prior to the date of the business relationship with the same person shall be included.
Not being or having been an auditor of the company, its subsidiaries, associates, major shareholders, or controlling persons of the company, and not being a significant shareholder, controlling person, or partner of an audit firm where an auditor of the company, its subsidiaries, associates, major shareholders, or controlling persons of the company is affiliated, unless such characteristics have ceased for at least two years prior to the appointment.
Not being or having been a professional service provider, including legal or financial advisors, who received service fees exceeding 2 million baht per year from the company, its subsidiaries, associates, major shareholders, or controlling persons of the company, and not being a significant shareholder, controlling person, or partner of such professional service provider, unless such characteristics have ceased for less than two years prior to the appointment.
Not being a director appointed as a representative of the company's directors, major shareholders, or shareholders who are related to the company's major shareholders.
Not engaging in a business of the same nature that is significantly competitive with the business of the company or its subsidiaries, or not being a significant partner in a partnership, or being a director involved in management, an employee, staff member, salaried advisor, or holding more than one percent of the total voting shares of another company that engages in a business of the same nature and is significantly competitive with the business of the company or its subsidiaries.
Possessing no other characteristics that would prevent the independent director from providing independent opinions on the company's operations. After being appointed as an independent director with characteristics in accordance with clauses 1) - 9), the independent director may be assigned by the Board of Directors to make decisions regarding the operations of the company, its subsidiaries, associates, major shareholders, or controlling persons of the company, with such decisions being made in the form of a collective decision.
Did Any Independent Director Have a Business or Professional Relationship?
No
Director Development
Director Development — Introduction
The Company aims to continuously promote the development of personnel at all levels to ensure they possess the knowledge and capabilities required for their work and duties at all times, and for career advancement. This is achieved by providing training, orientation, and fundamental organizational knowledge to new directors to ensure they understand their responsibilities. Furthermore, the Company encourages continuous development of knowledge and understanding among directors in relevant areas to enable them to perform their duties effectively, adapt to changing external circumstances, and contribute to sustainable development.
Evaluation of Board & Subcommittee Performance
Evaluation — Introduction
The Board of Directors mandates continuous annual self-assessment of performance so that the Board can collectively review the results and use the assessment results as a framework for considering improvements to address identified problems and obstacles, and to review the duties and responsibilities of the Board to ensure maximum efficiency and effectiveness for the benefit of the company, in accordance with the principles of good corporate governance for listed companies.
Criteria for Evaluating Board Performance
The Company prepares an assessment form based on the template provided by the Corporate Governance Development Department for the Capital Market, The Stock Exchange of Thailand, which divides assessment scores from 0 to 4 as follows: 0 = Strongly Disagree, 1 = Disagree, 2 = Agree, 3 = Agree to a great extent, 4 = Strongly Agree. All obtained scores are then processed and calculated as a percentage of the full score, with the following criteria:
1) Equal to or greater than 85% = Excellent
2) Equal to or greater than 75% = Very Good
3) Equal to or greater than 65% = Good
4) Equal to or greater than 50% = Fair
5) Less than 50% = Needs Improvement
Evaluation of Board Performance in the Past Year
The performance evaluation for the year 2025 consists of two types of evaluation forms: a self-assessment form for each committee to evaluate the overall performance of the committee as a whole, and a self-assessment form for individual committee members to evaluate the appropriateness of their duties as members. The overall evaluation results for all committees were at a very good to excellent level.
Evaluation Results
| Evaluated Body | Group — Carried Out? | Group — Grade / Average Score | Group — Grade / Full Score | Individual (Self-Assessment) — Carried Out? | Individual (Self-Assessment) — Grade / Average Score | Individual (Self-Assessment) — Grade / Full Score | Cross (Assessing Other Directors) — Carried Out? |
|---|---|---|---|---|---|---|---|
| Board Of Director | Y | 97.17 | 100 | Y | 96.75 | 100 | N |
| Audit Committee | Y | 96.67 | 100 | Y | 95.46 | 100 | N |
| Other Subcommittee | Y | 95.61 | 100 | Y | 95.83 | 100 | N |
| Other Subcommittee | Y | 99.54 | 100 | Y | 95.69 | 100 | N |
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance |
|---|
The Nomination and Remuneration Committee of Bangkok Lab & Cosmetic Public Company Limited ("the Company") is responsible for considering and establishing criteria and processes for recruiting suitable individuals to be appointed as directors, sub-committee members, and the Chief Executive Officer of the company. This includes selecting company directors, sub-committee members, and the Chief Executive Officer according to the established recruitment process, as well as considering the form and criteria for remuneration payment. The Nomination and Remuneration Committee comprises 3 directors: 2 independent directors and 1 executive director, with the Chairman of the Committee being an independent director. In 2025, the key aspects of its duties can be summarized as follows: 1. Recruitment and Selection of Individuals for Director Positions The Nomination and Remuneration Committee recruits directors and sub-committee members by screening individuals with suitable qualifications, knowledge, abilities, expertise, and experience beneficial to the company's business operations. They must meet relevant legal requirements and possess experience in various fields aligned with the company's strategies and business guidelines, capable of dedicating full time to their duties as directors for maximum benefit. All shareholders were given the opportunity to propose suitable candidates for election as directors between October 1, 2024, and December 30, 2024. Upon the deadline, no shareholders proposed any candidates for election as directors. Considering the aforementioned criteria, the Nomination and Remuneration Committee deemed it appropriate for the directors whose terms had expired to be re-appointed for another term. 2. Establishment and Review of Criteria and Methods for Recruiting and Appointing Company Directors The Nomination and Remuneration Committee reviewed the criteria and methods for recruiting and appointing company directors, considering the appropriateness of the number, structure, and composition of the Board. Nominated individuals were transparently vetted and selected to ensure they possess full qualifications and comply with legal requirements, as well as considering their integrity, knowledge, abilities, professional skills, expertise, and specific beneficial experience, all aligned with the company's business strategies. 3. Establishment and Review of Succession Plans for Senior Executives The Nomination and Remuneration Committee reviewed the succession plan by identifying key positions, defining qualifications and competencies, analyzing and evaluating potential successors, and providing guidelines for improving the Individual Development Plans (IDPs) of successors. This prepares for the appropriate recruitment and selection of individuals to fill critical positions, aligning with the company's direction. 4. Establishment and Review of Criteria and Methods for Determining Remuneration for Directors and Senior Executives The Nomination and Remuneration Committee reviewed the criteria and methods for determining the remuneration of directors and senior executives. The remuneration of directors was considered based on their knowledge, abilities, suitability for their duties and responsibilities, as well as business expansion, the company's performance, and its profit growth. It also involved a comparison with the remuneration paid to directors of leading companies in the same industry. As for the remuneration of senior executives (C-Level), it was determined based on their duties and responsibilities, the company's business performance, adherence to policies received from the Board of Directors, management under economic/social conditions, ability to develop the business, and annual improvements in operational efficiency. 5. Determination of Remuneration for the Board of Directors, Sub-Committees, and Senior Executives The Nomination and Remuneration Committee proposed the determination of remuneration for directors, sub-committee members, and senior executives based on the appropriateness of their duties, responsibilities, and the performance evaluation results of directors in the past year. This also included benchmarking against remuneration in the same or similar-sized industrial business groups to protect shareholders' interests, attract, and retain capable directors to work for the company. In 2025, the company utilized the director remuneration survey report from the Thai Institute of Directors (Thai IOD) as supporting information for proposing director remuneration to the Annual General Meeting of Shareholders appropriately for the following year. Furthermore, the determination of remuneration and other benefits for senior executives (C-Level) whose employment contracts are renewed was considered, along with providing a framework for determining senior executive (C-Level) remuneration as a guideline for future operations, to align with other companies in the industry and foster the company's long-term growth. 6. Self-Assessment of the Board of Directors, Sub-Committees, and Performance Evaluation of the Chief Executive Officer The Nomination and Remuneration Committee stipulated that the Board of Directors and sub-committees conduct self-assessments of their performance annually. This allows the committees to collectively review their performance and make improvements to ensure maximum efficiency and effectiveness, in line with the principles of good corporate governance for listed companies, as exemplified by the Capital Market Governance Development Department of the Stock Exchange of Thailand. Directors will be evaluated both as a committee and individually. For the 2025 performance evaluation of the Chief Executive Officer by non-executive directors, an additional section on the Chief Executive Officer's ESG performance has been included, and related issues are clearly integrated under this section to cover operations that require environmental and social responsibility, alongside good organizational management to achieve set goals and drive the business towards sustainability. 7. Reporting of Results The Nomination and Remuneration Committee proposed and provided opinions on the results of recruiting replacement directors for those whose terms had expired, as well as the determination of remuneration for directors and sub-committee members according to the established process, to the Board of Directors before submitting it to the Annual General Meeting of Shareholders for approval. Details of the recruitment and remuneration determination for the Board of Directors, sub-committees, and senior executives are disclosed in Form 56-1 One Report. In summary, the Nomination and Remuneration Committee has performed its duties in recruiting and determining the remuneration of directors and sub-committee members as stipulated in its charter, with responsibility, integrity, and independence in accordance with good corporate governance principles. This ensures that the process of recruiting and determining remuneration for directors and senior executives is transparent, auditable, and compliant with relevant laws and regulations, thereby building confidence among shareholders, investors, overall stakeholders, and enhancing the company's continuous development towards sustainability. |
Risk Management Committee of Bangkok Lab & Cosmetic Co., Ltd. (Public Company Limited) (“the Company”) is responsible for establishing risk management policies, overseeing the implementation of risk management systems or processes that cover the entire organization and group companies, and ensuring clear, efficient, and effective operational systems to mitigate risks, appropriately reduce impacts on the Company's business, enhance organizational resilience, and increase business opportunities. It continuously monitors and recommends measures for short-term, long-term, and emerging risks. The Risk Management Committee comprises 3 directors: 1 independent director and 2 executive directors, with the Chairman of the Committee being an independent director. In 2025, the key aspects of its duties can be summarized as follows: 1. Establishment and Review of Risk Management Policy The Risk Management Committee has reviewed the enterprise risk management policy to ensure that it can be effectively used as a guideline and principle for operations, and that it remains adequate and appropriate for the Group's operations. In addition to the commitment to creating added value for the Group and its stakeholders, consideration must also be given to managing the Group for sustainable growth across three dimensions: environmental, social, and governance. alongside stable business expansion 2. Oversight and Provision of Opinion on the Enterprise Risk Management Framework The Risk Management Committee has overseen and reviewed the enterprise-level risk management manual, which serves as the framework for risk management, risk management guidelines, and the acceptable risk level (Risk Appetite). This framework establishes assessment criteria to cover all potential risks that may affect the Company, ensuring that risk management is appropriate, efficient, and in line with international standards. 3. Consideration and Provision of Opinion on Risk Management Approaches and Measures The Risk Management Committee has reviewed and provided opinions on the annual enterprise-level risks before seeking approval from the Audit Committee and subsequently presenting them to the Board of Directors. The risk items are considered to align with the organization's strategies, goals, and business direction, including environmental issues. This process involves defining the context, identifying, analyzing, and assessing risks to establish risk management measures, as well as monitoring and reviewing risk management outcomes to ensure they are at an acceptable level and achieve defined objectives. The Risk Management Committee has appointed a Risk Management Working Group, comprising members from various departments within the company, to ensure that risks are identified across all operational processes. 4. Monitoring and Oversight of Risk Management Processes The Risk Management Committee has monitored operations with the Risk Management Working Group once per quarter, covering: 1) Strategic risks, such as the introduction of new products to the market not meeting set targets, or greenhouse gas emission management exceeding set targets; 2) Operational risks, such as excess finished goods inventory or cybersecurity threats to information technology systems; 3) Financial reporting and numerical risks, such as losses from exchange rate fluctuations; and 4) Compliance risks, such as potential product liability complaints. This also includes monitoring and assessing new risks that may arise during the current year and in the future. 5. Promoting and Supporting Risk Management The Risk Management Committee contributes to laying the foundation for the Company's systematic risk management by operating in accordance with international standards. It provides advice to the Board of Directors, management, and the Risk Management Working Group, and enhances knowledge and skills through participation in external training programs for practical application in operations. Furthermore, it promotes the organization's use of risk management as a tool to achieve objectives and goals in line with the organization's vision and mission, oversees and supports the success of enterprise risk management, and recommends prevention methods and ways to reduce risk levels to an acceptable degree to enhance stakeholder value. All executives and employees are responsible for risk management and must adhere to the roles, duties, responsibilities, and risk management processes defined in the Group's Risk Management Manual. 6. Review and Reporting The Risk Management Committee reports its operational results to the Audit Committee and the Board of Directors quarterly. It also reviews risk management information and risk factors in the annual information statement to assure shareholders that the Company analyzes significant risk issues related to business objectives and has systematic risk management measures in place to address various risks. However, the Company still faces uncertainties from other environmental factors. Therefore, there is a process to monitor and assess new potential risks (Emerging Risks) during 2025 and in the future to analyze measures and approaches for timely management and response to such risks. The review results include emerging risk issues such as the Thai-EU Free Trade Agreement (FTA Thai-EU), which may affect patent lifespans; competition from Chinese products with lower production costs; increased import tariffs by the United States on pharmaceutical raw materials or other components; and natural disasters like earthquakes and floods. These factors will directly and indirectly impact product demand, selling prices, raw material costs, and the Company's strategic drive for sustainability. The Risk Management Committee continues to closely monitor the situation and provide appropriate comments and recommendations to management. In summary, the Risk Management Committee has performed its duties in managing the organization's significant risks as stipulated in its charter, utilizing its knowledge and capabilities with diligence and prudence in its operations. It has maintained independence and adhered to good corporate governance principles for the benefit of the Company and all stakeholders. The Committee has also received excellent information and cooperation from the Company's management, which indicates that the Company has adequate and effective risk management practices in place, consistent with international standards. |
Meeting Attendance & Remuneration
Meeting Attendance — Sub-section Introduction
Meeting dates for the Board of Directors and sub-committees will be set as an annual meeting plan, with important agenda items for consideration specified in advance according to the meeting cycle. The Board of Directors is scheduled to meet every Monday of the week when financial statements must be disclosed and submitted to the Stock Exchange, and extraordinary meetings may be convened as necessary. The Company Secretary is responsible for sending meeting invitations, agendas, and supporting documents to the directors at least 7 days in advance to allow directors sufficient time for prior study before attending the meeting, unless it is an urgent necessity to protect the rights or benefits of the company, in which case the meeting may be called by other means or scheduled sooner. A Board of Directors meeting requires at least half of the total number of directors to be present to constitute a quorum. In the event that the Chairman of the Board is not present at the meeting or is unable to perform duties, if there is a Vice Chairman of the Board, the Vice Chairman shall preside over the meeting. However, if there is no Vice Chairman of the Board, or if one exists but is not present
at that meeting or is unable to perform duties, the directors present at the meeting shall elect one director to preside over the meeting. Furthermore, when considering any matter, directors have the right to request to view or inspect relevant documents and may also request relevant management to attend the meeting to clarify additional information. The chairman of each committee acts as the presiding officer for meetings of that committee. They are responsible for ensuring and allocating sufficient time for each agenda item, allowing directors to freely discuss and express opinions on important issues, while fairly considering the interests of shareholders and stakeholders. Directors with a conflict of interest in the matter under consideration do not have the right to vote on that matter and must leave the meeting during the discussion of the related issue. Each director has one vote. Resolutions shall be passed by a majority vote. If the votes are tied, the presiding chairman shall cast an additional vote as a tie-breaker. If any director objects to such a resolution, their objection shall be recorded in the meeting minutes.
In 2025, each director attended at least 85% of all scheduled board meetings. Meetings were held in both physical conference and hybrid formats, utilizing current communication technologies to their full advantage.
Types of Remuneration of the Board of Directors
The remuneration for the company's directors and sub-committee members must be considered by the Nomination and Remuneration Committee in accordance with the policy for determining remuneration for directors and senior executives. This consideration is based on their roles, duties, responsibilities, performance, and the company's operating results, along with benchmarking against the remuneration of directors in similar industries in terms of characteristics and size, before being proposed to the Board of Directors and the Shareholders' Meeting for approval.
Director remuneration rates consist of
List of Directors | Type of Director | Director Remuneration (Baht) | |
Meeting allowance For the year 2024 (Per meeting) | Meeting allowance For the year 2025 (Per meeting) | ||
Board of Directors | Chairman of the Committee (Independent Director) Director (Independent Director) Director (Executive) Director (Non-Executive) | 30,000.00 25,000.00 - - | 60,000.00 50,000.00 - |
Audit Committee | Chairman of the Committee (Independent Director) Director (Independent Director) | 30,000.00 25,000.00 | 50,000.00 45,000.00 |
Nomination and Remuneration Committee | Chairman of the Committee (Independent Director) Director (Independent Director) Director (Executive) Director (Non-Executive) | 30,000.00 25,000.00 - - | 50,000.00 45,000.00 - - |
Risk Management Committee | Chairman of the Committee (Independent Director) Director (Independent Director) Director (Executive) Director (Non-Executive) (if any) | 30,000.00 25,000.00 - - | 50,000.00 45,000.00 - - |
Executive Committee | Chairman of the Executive Board Director (Executive) Director (Non-Executive) | - - - | 4,000.00 4,000.00 4,000.00 |
The Annual General Meeting of Shareholders for the year 2025, held on April 1, 2025, set the remuneration for directors and sub-committee members at a maximum of 2,400,000 Baht (Two Million Four Hundred Thousand Baht only) in the form of a per-meeting allowance, with no other benefits, similar to the previous year. No meeting allowance will be paid to directors and sub-committee members who are executives of the company and within the group of companies, with the exception of directors on the Executive Committee.
Remuneration of the Board — Introduction
In 2025, remuneration totaling 1,956,000 Baht was paid to directors and sub-committee members for the year, which was within the approved framework.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Oversight Mechanism — Introduction
The Company has an investment policy in subsidiaries and associated companies that aligns with the Company's goals, vision, and growth strategies, serving as an important guideline for supervising the operations of subsidiaries and associated companies. This will lead to increased performance or profits for the Company, enhancing stability or investing in businesses that provide synergy with the Company. Furthermore, the Company, its subsidiaries, and/or associated companies may consider investing in other businesses if such businesses have growth potential or can extend existing businesses, or are beneficial to the Group's businesses, and can generate good returns on investment. The Company will consider the investment proportion, expected profits, potential risks, and the Company's financial status, including analyzing the feasibility of the investment and assessing its potential, before making decisions on various projects. The approval for such investments must be considered by the Board of Directors' meeting and/or the Shareholders' meeting (as the case may be). The request for approval of such investments must comply with public company laws, securities and exchange laws, as well as announcements, regulations, and various criteria related to the Capital Market Supervisory Board, the Securities and Exchange Commission, and the Stock Exchange of Thailand, which includes criteria regarding the acquisition or disposition of assets, connected transactions, and information disclosure.
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
To comply with good corporate governance principles regarding the establishment of a framework and mechanisms for overseeing policies and operations in subsidiaries and other significantly invested entities at a level appropriate for each entity, the Company has established a framework for supervising and monitoring the performance of its subsidiaries and associates at an appropriate level to efficiently safeguard the Company's investment interests, thereby enhancing shareholder confidence. Details are as follows:
The Company shall appoint individuals as its representatives to serve as directors or executives of its subsidiaries and/or associates, in proportion to its shareholding in each company, to oversee that the subsidiaries and/or associates operate in compliance with various policies, regulations, laws, and good corporate governance guidelines for listed companies, including various related regulations and rules of the Capital Market Supervisory Board, the SEC Office, and the Stock Exchange of Thailand. This shall apply unless the Company's Board of Directors deems that the board structure and management structure with fewer Company representatives as directors or executives in such subsidiaries or associates than the Company's shareholding proportion would not affect the Company's power to determine policies and undertake significant matters or matters affecting the financial position and operating results of that subsidiary or associate, or if there is an appropriate balance of power in that subsidiary or associate, or if it is in accordance with the shareholders' agreement of that subsidiary or associate. The appointment of the Company's representatives as directors or executives in each subsidiary and/or associate must be considered and approved by the Company's Board of Directors meeting, taking into account the suitability of each company, unless in cases where such subsidiary or associate is a small company acting as an operating arm of the business, the Company's Board of Directors may delegate the appointment authority to the Chief Executive Officer.
The directors and executives of each subsidiary shall have significant duties and responsibilities under relevant laws, such as disclosing information regarding their financial position and operating results to the Company, by applying relevant laws, as well as announcements, regulations, and various related criteria of the Capital Market Supervisory Board, the SEC Office, and the Stock Exchange of Thailand by analogy. This also includes disclosing and submitting information on their interests and those of related persons to the Company's Board of Directors, to inform them of relationships and transactions with the Company and/or its subsidiaries that may give rise to conflicts of interest, and to avoid engaging in transactions that may give rise to conflicts of interest.
For any transaction or operation by a subsidiary that is significant or affects the Company's financial position and operations, or falls under the acquisition or disposal of assets as per the relevant announcement on the acquisition or disposal of assets, or a connected transaction as per the relevant announcement on connected transactions, which would require the Company to seek approval from the Company's Board of Directors meeting and/or the Company's shareholders' meeting and/or relevant authorities as per the law before entering into the transaction (as the case may be), the subsidiary may only enter into such transaction or operation after receiving approval from the Company's Board of Directors meeting and/or the Company's shareholders' meeting and/or relevant authorities (as the case may be). Furthermore, in the event of certain transactions or occurrences by a subsidiary that fall under the categories specified in the Stock Exchange's regulations concerning the disclosure of information and operations of listed companies regarding the acquisition or disposal of assets by listed companies, the Company is obliged to disclose information about such transactions to the Stock Exchange of Thailand in accordance with the criteria stipulated in the relevant announcements. The representative director of such subsidiary has a duty to immediately notify the Company's management upon learning that the subsidiary plans to enter into such a transaction or event.
The Company shall establish necessary plans and operations to ensure that its subsidiaries and/or associates disclose information regarding their operating results and financial position, and the Company shall undertake necessary actions and monitor that its subsidiaries and/or associates have adequate and appropriate information disclosure systems and internal control systems for their business operations.
The Company's representative directors in subsidiaries and/or associates must monitor and undertake necessary actions to ensure the regular establishment, review, and update of various important policies and plans related to the business operations of the subsidiaries and/or associates, to keep them current and appropriate for the business environment.
In the case of a joint venture that is a subsidiary, the representative director in the subsidiary must consider, monitor, and provide necessary advice to the subsidiary, including ensuring the establishment of internal control systems, risk management systems, and anti-corruption systems, as well as defining appropriate and stringent measures for monitoring the subsidiary's performance. Furthermore, clear, efficient, and effective operational systems should be established for business operations.
The Company's representative directors in subsidiaries and/or associates must obtain approval from the Company's Board of Directors meeting before casting votes at the Board of Directors meeting of the subsidiary and/or associate on matters deemed significant for the operations of the subsidiary and/or associate, such as the appointment or nomination of individuals as directors in the subsidiary and/or associate, at least in proportion to the Company's shareholding in such subsidiary and/or associate; the purchase or sale of shares, businesses, or significant assets; the increase or decrease of capital of the subsidiary and/or associate; the merger or dissolution of the subsidiary and/or associate; the approval of the annual budget of the subsidiary and/or associate; and any other items deemed significant and, if undertaken, would have a significant impact on the Company, unless such matters are specified in the Company's Delegation of Authority, including any other items deemed material and, if undertaken, would have a significant impact on the Company.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
| Other important transactions |
| Acquisition or disposal of assets |
| Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business |
Board Duty Performance — Overview
Board Duty Performance — Overall Description
In 2025, the Board of Directors performed its duties in overseeing the Company’s operations in accordance with its roles and authorities. The Board reviewed the vision, strategies, and key policies to ensure alignment with the changing business environment, and considered significant matters presented by management to ensure that operations were conducted in line with the established direction and that material risks were appropriately managed.
The Board places importance on conducting business in accordance with quality and safety standards, with strict compliance with applicable laws and adherence to the Company’s core value of Care for the quality of life and health of the public. This includes responsibility toward society, efficient use of resources, and consideration of environmental impacts throughout the supply chain.
The Board emphasizes good corporate governance, transparency, accountability, and appropriate disclosure of information in order to strengthen the confidence of shareholders, customers, and stakeholders, and to support the Company’s long-term sustainable growth.
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
Audit Committee of Bangkok Lab & Cosmetic Public Company Limited (Public Company Limited) ("the Company") has performed its duties independently and transparently to primarily safeguard the Company's interests and to operate within the scope specified in the Audit Committee Charter. The Audit Committee places importance on reviewing financial reports, related party transactions, internal control systems, and internal audits, which are crucial for the Company's business operations and good corporate governance, and to build trust and confidence among shareholders and stakeholders of The Company's Audit Committee comprises 3 independent directors, one of whom possesses expertise in accounting/finance. In 2025, the key aspects of its duties can be summarized as follows:
1. Review of financial statements.
The Audit Committee reviewed the separate financial statements and consolidated financial statements of the Group, both quarterly and annually for 2025, which had been audited by certified public accountants. This involved reviewing significant figures and information in the financial statements, including material issues and special items, and receiving clarifications and confirmations from the auditors and relevant management regarding the data used in preparing the financial statements. It also reviewed the disclosure of notes to the financial statements to ensure compliance with legal requirements, financial reporting standards, and generally accepted accounting standards, and that information in the financial statements was disclosed accurately, adequately, and timely. The Audit Committee approved the said financial statements, which had been audited and reviewed by the certified public accountants. In 2025, the certified public accountants issued an unqualified opinion on the financial statements.
2. Review of the internal control system.
The Audit Committee reviewed the assessment of the adequacy of the internal control system based on the assessment form of the Securities and Exchange Commission of Thailand (SEC). The external internal auditor had already prepared a report on the results of the assessment of the adequacy of the internal control system for the year 2025 as audit evidence. The Audit Committee is of the opinion that the Company's practices comply with the internal control guidelines prescribed by the SEC, and that significant internal control measures related to operations, risk management, and oversight by management and the Board are adequately established.
3. Oversight of internal audit functions.
The Audit Committee considered and reviewed the scope of work, responsibilities, the 2025 annual internal audit plan, and the performance of the external internal auditor in accordance with the plan, as well as monitoring the resolution of various issues of the Company, with audit results reported directly to the Audit Committee once per quarter. This includes supporting internal auditors to perform their duties independently and with sufficient resources to achieve the audit plan, and providing beneficial recommendations for internal audits to ensure that the Company has appropriate and robust internal control and internal audit systems to oversee operations in line with goals, objectives, and relevant laws and regulations effectively. This also aims to prevent asset damage from fraud and ensure the disclosure of accurate and reliable information, without any material errors that could affect the Company's financial statements and business operations. From this review, the Audit Committee is of the opinion that the overall internal control system of the Group is appropriate and adequate, and no material deficiencies affecting the financial statements and operations of the Company were found.
4. Review and provide opinions on related party transactions or transactions that may involve conflicts of interest.
The Audit Committee reviewed the related party transactions that occurred to ensure they were complete, accurate, reasonable, fair, and in compliance with relevant regulations and rules. The Audit Committee is of the opinion that the related party transactions were reasonable, did not involve the transfer of benefits from BLC or its shareholders, but rather were transactions where BLC prioritized the best interests of BLC and all shareholders. These transactions will be conducted in accordance with the Securities and Exchange Act, regulations, announcements, orders, or requirements of the Capital Market Supervisory Board, the SEC Office, and the Stock Exchange.
5. Consideration for selection, nomination, and remuneration of the auditor.
The Audit Committee considered the selection, nomination, and proposed remuneration of the auditor for the year 2024, to be presented to the Board of Directors and the Annual General Meeting of Shareholders for approval. This consideration and evaluation were based on the auditor's independence, knowledge, capabilities, experience, the quality of their audit work in the past fiscal year, and the appropriateness of the audit fees, as well as other non-audit services from the same audit firm. In 2025, the Audit Committee held one independent discussion with the auditor without management present. The Audit Committee is of the opinion that the auditor from KPMG Phoomchai Audit Ltd. possesses the qualifications according to the aforementioned criteria to serve as the Company's auditor.
6. Review of good corporate governance.
The Audit Committee has reviewed and approved the Company's relevant policies before submitting them to the Board of Directors, including the Good Corporate Governance Policy, the Related Party Transactions Policy, the Internal Control and Internal Audit Policy, the Anti-Corruption Policy, the Whistleblowing or Complaint Policy, the Conflict of Interest Prevention Policy, the Insider Trading and Securities Trading Policy, the Information Disclosure and Financial Statement Submission Policy, and significant accounting policies. It also reviewed the Company's operations to ensure compliance with relevant regulations and laws governing the Company's business operations, aiming for accurate, efficient, transparent, and reasonable operations that are auditable, responsible to all stakeholders and related parties, and create sustainable value for the business, thereby building confidence among shareholders. The Audit Committee is of the opinion that the Company has overseen and reviewed the operations of various departments to ensure appropriate compliance with relevant laws, regulations, and rules.
7. Review of the risk management process.
The Audit Committee reviewed the appropriateness of the risk assessment system, risk control system, and risk monitoring and reporting system to ensure that the risk management approach aligns with the mission and business plan of the Group and covers all operational processes in accordance with COSO ERM operational standards. This was based on the results of quarterly risk management assessments and the summary of the 2024 annual risk management results from the Risk Management Committee. The Audit Committee is of the opinion that the Company's risk management system is sufficiently effective and compliant with standards.
In summary, the Audit Committee has performed its duties as specified in the Audit Committee Charter, utilizing its knowledge and abilities with prudence and diligence, and maintaining independence in its operations. It has received excellent information and cooperation from the Company's management to ensure that various aspects of the corporate governance system are appropriate, adequate, and effective, for the utmost benefit of all stakeholders.
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
Pharmacist Tira Thanajirawat Appointed as a member of the Executive Board by the Board of Directors Meeting No. 3/2568 on March 10, 2568

